Iregene Therapeutics Co., Ltd.
Clinical trials sponsored by Iregene Therapeutics Co., Ltd., explained in plain language.
-
Could a cell transplant ease advanced Parkinson's? new trial begins
Disease control Recruiting nowThis early-stage trial tests a new treatment called NouvNeu001 in 5 people with advanced Parkinson's disease. The goal is to see if it is safe and if it can improve movement and other symptoms. Participants receive a transplant of special cells and are followed for up to 96 weeks…
Phase: PHASE1, PHASE2 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:30 UTC
-
Brain cell injection trial offers hope for rare Parkinson's-like disease
Disease control Recruiting nowThis early-stage trial tests a single injection of special brain cells (dopaminergic progenitor cells) into a specific area of the brain for people with Multiple System Atrophy (MSA), a rare and severe neurological disorder. The main goal is to check if the procedure is safe and …
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:24 UTC